As of the end of November, Livzon Pharma (01513) has repurchased a total of 16.1933 million A shares.
Li Zhu Pharmaceuticals (01513) announced that as of November 30, 2025, the company repurchased a total of 16.1933 million A-shares through centralized bidding trading, accounting for 1.79% of the company's total share capital. The highest purchase price was RMB 41.99 per share, the lowest was RMB 33.21 per share, and the total amount spent was RMB 600 million (excluding transaction fees). The repurchase mentioned above is in accordance with the company's established share repurchase plan.
LIVZON PHARMA (01513) announced that as of November 30, 2025, the company repurchased a total of 16.1933 million A shares through centralized bidding trading, accounting for 1.79% of the company's total share capital. The highest purchase price was RMB 41.99 per share, and the lowest price was RMB 33.21 per share. The total amount of funds used was RMB 600 million (excluding transaction fees). The repurchase mentioned above is in line with the company's established share repurchase scheme.
Related Articles

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


